| 300 |
29 bc |
150 |
29 bc |
107 |
36 b |
| 400 |
30 bc |
200 |
29 bc |
108 |
31 c |
| 500 |
27 cd |
250 |
25 cd |
109 |
24 cd |
| 600 |
27 cd |
300 |
19 de |
|
|
| 700 |
18 de |
350 |
13 ef |
|
|
| 800 |
10 f |
400 |
7 f |
|
|
| 900 |
5 f |
450 |
7 f |
|
|
| LSD |
5.6 |
|
|
|
|
| Regression |
y = −0.037x + 42.67 |
|
y = −0.08x + 42.81 |
|
y = −1.98x + 47.88 |
| r2 |
0.91 |
|
0.95 |
|
0.67 |
| Effective dose (ED50) |
577 µg∙ml−1 |
267 µg∙ml−1 |
|
|
|
|
|
Gray mould disease severity (%) |
|
|
|
|
| 0 |
85 a |
0 |
85 a |
0 |
85 a |
| 200 |
85 a |
200 |
80 b |
105 |
85 a |
| 400 |
80 a |
400 |
65 c |
106 |
80 a |
| 600 |
70 b |
600 |
53 c |
107 |
74 ab |
| 800 |
55 c |
800 |
35 d |
108 |
65 bc |
| 1000 |
30 d |
1000 |
20 f |
109 |
55 c |
| LSD |
|
|
|
|
12.5 |
| Regression |
y = −0.05x + 94.28 |
|
y = −0.06x + 90.04 |
|
y = −2.99x + 91.44 |
| r2 |
0.85 |
|
0.98 |
|
r² = 0.63 |
| Effective dose (ED50) |
943 µg∙ml−1 |
|
750 µg∙ml−1 |
|
|